These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 13671094)

  • 1. [Behavior of intramuscular, intravenous and oral gamma globulin].
    MARTIN DU PAN R; SCHEIDEGGER JJ; WENGER P; KOECHLI B; ROUX J
    Blut; 1959 Apr; 5(2):104-14. PubMed ID: 13671094
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical use of intravenous gamma-globulin.
    Barandun S; Morell A; Skvaril F
    Bibl Haematol; 1980; (46):170-4. PubMed ID: 6155121
    [No Abstract]   [Full Text] [Related]  

  • 3. Tolerance of intravenous gamma globulin.
    Rewald E; Suringar F
    Bibl Haematol; 1968; 29():337-9. PubMed ID: 4178391
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of antibody deficiency syndromes with subcutaneous infusion of gamma globulin.
    Roord JJ; van der Meer JW; Kuis W; van Furth R
    Birth Defects Orig Artic Ser; 1983; 19(3):217-21. PubMed ID: 6197108
    [No Abstract]   [Full Text] [Related]  

  • 5. [Epidemiological effectiveness of different doses of gamma globulin in infectious hepatitis. 3. Epidemiological effectiveness of 1 per cent gamma globulin in a single intramuscular injection].
    Spotarenko SS; Karon BI; Kolmogorov LF; Radomskaia FS
    Zh Mikrobiol Epidemiol Immunobiol; 1973 Dec; 50(12):30-4. PubMed ID: 4132081
    [No Abstract]   [Full Text] [Related]  

  • 6. The place of the human gamma globulin in modern therapeutics.
    Schless AP; Harell GS
    Triangle; 1969; 9(2):74-8. PubMed ID: 4107076
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of intravenous pH 4.0 treated gamma globulin in humoral immunodeficiency disease.
    Cunningham-Rundles C; Smithwick EM; Siegal FP; Day NK; Lion A; O'Malley J; Barandun S; Good RA
    Birth Defects Orig Artic Ser; 1983; 19(3):201-3. PubMed ID: 6197105
    [No Abstract]   [Full Text] [Related]  

  • 8. [Anti-D gamma globulin given intravenously for the prevention of anti-Rh immunization].
    Jouvenceaux A; Adenot N; Berthoux F; Revol L
    Prog Immunobiol Stand; 1970; 4():291-5. PubMed ID: 4098267
    [No Abstract]   [Full Text] [Related]  

  • 9. [Lyophilized anti-D gamma globulin given intravenously for the prevention of anti-Rh immunization].
    Jouvenceaux A; Adenot N; Berthoux F; Revol L
    Rev Fr Transfus; 1969; 12(1):Suppl:341-7. PubMed ID: 4193519
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intensity of formation of antigammaglobulins in healthy children after administration of different doses of gamma globulin].
    Fokina TV; Kudashov NI; Potemkina EE
    Pediatriia; 1974 Dec; (12):20-4. PubMed ID: 4141078
    [No Abstract]   [Full Text] [Related]  

  • 11. [Period of survival of serum antibodies in healthy persons subjected to intramuscular injections of antileptospirosis gamma-globulin].
    Zorina ZM; Ivanova MN; Martynova AP
    Sov Med; 1973 Mar; 36(3):146. PubMed ID: 4127893
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rectal absorption of bovine gamma globulin labeled with I-125].
    Orlando P; Raiteri M; Massari P
    Farmaco Prat; 1972 Jun; 27(6):338-45. PubMed ID: 4113465
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical evaluation of Pseudomonas hyperimmune globulin and plasma.
    Jones CE; Alexander JW; Fisher MW
    Surg Forum; 1970; 21():238-40. PubMed ID: 4105882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Possibility of using the BI-3 jet injector for gamma globulin administration].
    Karon BI; Naumenko IuI; Spotarenko SS; Egorov VV; Bakhur EA
    Zh Mikrobiol Epidemiol Immunobiol; 1979 Aug; (8):17-20. PubMed ID: 91282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Subcutaneous gamma globulin substitution in X-linked agammaglobulinemia].
    Maródi L; Szabó I; Pálóczi K; Karmazsin L
    Orv Hetil; 1986 Jul; 127(27):1621-3. PubMed ID: 2426645
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the problem of antibody formation against Gm in adults following repeated parenteral administration of homologous gamma globulin].
    Auerswald W; Bodis-Wollner I; Kiesewetter E; Mickerts D; Speiser P
    Wien Med Wochenschr; 1967 Nov; 117(45):1006-8. PubMed ID: 4173601
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical experiences in the use of intravenously injectable tetanus-immune human gamma globulin TIG(i). I. Serum antitoxin levels following injection (author's transl)].
    Ebisawa I; Matsuhashi C; Yamamoto A; Kurosu Y; Otsuka T
    Kansenshogaku Zasshi; 1981 Feb; 55(2):92-100. PubMed ID: 6167649
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effectiveness of decreased doses of gamma-globulin (1 ml) in the prevention of measles].
    Ignat'eva GV; Saraeva NT; Mastiukova IuN; Khrometskaia TM; Ledeneva AG
    Zh Mikrobiol Epidemiol Immunobiol; 1966 Nov; 43(11):144-5. PubMed ID: 4185459
    [No Abstract]   [Full Text] [Related]  

  • 19. Isolation of Non-modified gamma globulin for intravenous use.
    Schneider W; Wolter D; McCarty LJ
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1976; 103(6):938-45. PubMed ID: 64437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of cyclic neutropenia by intramuscular gamma globulin in a case of common variable immunodeficiency with predominantly antibody deficiency.
    Agarwal BR; Currimbhoy Z
    Indian Pediatr; 1994 Mar; 31(3):320-2. PubMed ID: 7534749
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.